Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

2.9%

6 terminated/withdrawn out of 205 trials

Success Rate

78.6%

-7.9% vs industry average

Late-Stage Pipeline

15%

31 trials in Phase 3/4

Results Transparency

5%

1 of 22 completed trials have results

Key Signals

72 recruiting1 with results

Enrollment Performance

Analytics

N/A
49(31.4%)
Phase 2
31(19.9%)
Phase 1
26(16.7%)
Early Phase 1
19(12.2%)
Phase 3
19(12.2%)
Phase 4
12(7.7%)
156Total
N/A(49)
Phase 2(31)
Phase 1(26)
Early Phase 1(19)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (205)

Showing 20 of 205 trials
NCT07620626Recruiting

Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment

Role: collaborator

NCT07619027Phase 4Not Yet Recruiting

Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney Transplantation

Role: lead

NCT07611656Not ApplicableRecruiting

A Multicenter, Prospective, Randomized Controlled Clinical Study on the Effect of Hysteroscopic Uterine Septum Resection on IVF-ET Outcomes in Infertile Patients With Non-recurrent Miscarriage

Role: collaborator

NCT06544083Recruiting

Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

Role: collaborator

NCT07602504Recruiting

China Metastatic Liver Cancer Clinical Registry Cohort Database

Role: lead

NCT07581795Phase 2Not Yet Recruiting

Study of Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast Cancer

Role: collaborator

NCT07150624Phase 4Recruiting

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

Role: lead

NCT07562763Completed

Estimation and Prediction of Individual Benefit From Postoperative Adjuvant Transcatheter Arterial Chemoembolization For Patients With Hepatocellular Carcinoma

Role: lead

NCT06140992Recruiting

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Role: collaborator

NCT07533825Not ApplicableEnrolling By Invitation

Laparoscopic Staging for Stage III Gastric Cancer

Role: collaborator

NCT06534255Phase 1Active Not Recruiting

A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation.

Role: lead

NCT07195084Not ApplicableRecruiting

To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer

Role: collaborator

NCT07523464Phase 1Not Yet Recruiting

Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC

Role: lead

NCT06321198Not ApplicableRecruiting

A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

Role: lead

NCT07481656Phase 4Not Yet Recruiting

Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)

Role: lead

NCT05029141Phase 2Active Not Recruiting

New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Role: collaborator

NCT07462676Not ApplicableNot Yet Recruiting

Simultaneous Vs Staged VPS and CP :A Multi-cnter RCT.

Role: lead

NCT07446452Phase 2Recruiting

Disitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II Study

Role: collaborator

NCT07130955Not ApplicableEnrolling By Invitation

A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease

Role: collaborator

NCT07211048Not ApplicableRecruiting

Anti CD19 Gene Therapy for B-cell Lymphoma

Role: lead